Home / Topics / Pharmaceuticals
Topic filterPharmaceuticals news API
Drug development, approvals, pricing and supply. Pass topic=WB_1350_PHARMACEUTICALS to filter.
What does the pharmaceuticals topic actually cover?
Development and trial results, regulatory approvals, pricing and reimbursement decisions, and manufacturing and supply. Distinct from healthcare provision: this is the industry rather than the system.
How do I filter news to pharmaceuticals?
Pass topic=WB_1350_PHARMACEUTICALS on /search or /stories. Pair with an organization rather than a drug name where you can — companies are stable entities and drug names change between the development code, the generic name and the brand, often mid-story. Hybrid mode helps bridge those three, which a keyword query treats as unrelated.
GET /stories?topic=WB_1350_PHARMACEUTICALS&mode=hybrid&from=2026-07-24&limit=20What catches people out with pharmaceuticals coverage?
Reading approval coverage as availability. A drug can be approved, covered enthusiastically everywhere, and remain unavailable in most markets for years pending reimbursement decisions that are covered locally, quietly, and in the local language. The gap between approval and access is where the story is and it is nearly invisible in English-language coverage.
Who publishes on it
Pharmaceutical trade press covers pipelines and regulatory process closely. Financial press covers the same events as company news with a different emphasis. Regulator communications are primary. Company press offices originate a very large share, and negative results are announced far less enthusiastically than positive ones.
In the sample, 321 outlets carry pharmaceuticals coverage at about 1
articles each. The busiest is cfi.net.cn at roughly 3%,
and cfi.net.cn, china.com, tribunnews.com account for about 7% between them.
Flat enough that volume here translates fairly directly into independent reporting rather than one newsroom publishing repeatedly.
What it is best for
Best for approvals, pipeline milestones and supply disruptions — all documented and dated. Weakest for efficacy, which is settled in journals and regulatory review rather than in coverage, and for pricing, which is negotiated confidentially in most markets.
Monitoring it over time
Conference and regulatory decision calendars drive most of the structure, and both are published well in advance. Supply disruption is the exception worth alerting on in real time: shortages appear first in pharmacy and clinical trade outlets, well before any general coverage, and the lead time is genuinely useful.
Which signals pair with pharmaceuticals?
Topic filtering answers what an article is about. Signals answer how strongly it reads that way and in what register, so combining them is usually sharper than either alone.
healthcare— Care delivery, providers, public healthhealth_security— Outbreaks and health emergenciessupply_disruption— Interrupted production, logistics, shortage
GET /search?topic=WB_1350_PHARMACEUTICALS&signal=healthcare&signal_min=0.25Recent coverage
From the index on 2026-07-31, in the language each was published in.
- Food Dive: Food Industry News and Analysis
- What is HC Wainwright's Forecast for AGIO FY2030 Earnings?
- Sun Pharma Q1 results: Profit rises 27% to Rs 2,895 crore; revenue climbs 10%
- Dr. Richard Feldman: We'll pay price for environmental rollbacks
- NDLEA discovers 3 drug warehouses, seizes 2,596kg narcotics
- Post-finasteride syndrome: pharmacists must lead the conversation on patient safety
- Liontrust Investment Partners LLP Decreases Stake in West Pharmaceutical Services, Inc. $WST
- The Trump administration is ending a Medicare drug subsidy program. Here's how it could affect costs
Who covers it
cfi.net.cn · china.com · tribunnews.com · varesenews.it · haberler.com · baomoi.com · viveresanbenedetto.it · news.yam.md · dailypolitical.com · jrj.com.cn · zazoom.it · themarketsdaily.com
Counts are provisional pending a snapshot against the API.